The results of the Phase III AMBAR trial were presented at the 2021 EAN meeting. Read on to learn more…

Highlights from AAN 2021 in headache and stroke! Learn more about the major clinical trials reported at this years’ meeting.

Discover updates from major clinical trials in myasthenia gravis, Parkinson’s disease & ALS presented at AAN 2021!

Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy1 and the most common type of drug-resistant epilepsy.2…

Multiple sclerosis (MS) is a long-life condition that affects the brain and spinal cord resulting in impaired vision, limb movement,…

Amyotrophic lateral sclerosis (ALS) is an aggressive neurodegenerative disease that is fatal. The disease affects both upper and lower motor neurons…

Huntington’s disease (HD) is an autosomal dominant inherited neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin…